Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.

Saved in:
Bibliographic Details
Title: Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.
Authors: Schneider-Hohendorf T; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Gerdes LA; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Pignolet B; Toulouse Institute for infectious and inflammatory diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France., Gittelman R; Adaptive Biotechnologies, Seattle, WA., Ostkamp P; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Rubelt F; Roche Sequencing Solutions, Pleasanton, CA., Raposo C; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Tackenberg B; F. Hoffmann-La Roche Ltd, Basel, Switzerland.; Philipps-University, Department of Neurology, Marburg, Germany., Riepenhausen M; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Janoschka C; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Wünsch C; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Bucciarelli F; Toulouse Institute for infectious and inflammatory diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France., Flierl-Hecht A; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Beltrán E; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Kümpfel T; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Anslinger K; Institute of Legal Medicine, Ludwig-Maximilians Universität München, Munich, Germany., Gross CC; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Chapman H; Adaptive Biotechnologies, Seattle, WA., Kaplan I; Adaptive Biotechnologies, Seattle, WA., Brassat D; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wekerle H; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.; Institute for Biological Intelligence, Martinsried, Germany., Kerschensteiner M; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany.; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany., Klotz L; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Lünemann JD; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Hohlfeld R; Institute of Clinical Neuroimmunology, University Hospital and Biomedical Center, Ludwig-Maximilians Universität München, Munich, Germany.; Biomedical Center, Faculty of Medicine, Ludwig-Maximilians Universität München, Martinsried, Germany., Liblau R; Toulouse Institute for infectious and inflammatory diseases (Infinity), University of Toulouse, Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Université Paul Sabatier, Toulouse, France., Wiendl H; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany., Schwab N; Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
Source: The Journal of experimental medicine [J Exp Med] 2022 Nov 07; Vol. 219 (11). Date of Electronic Publication: 2022 Sep 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Rockefeller University Press Country of Publication: United States NLM ID: 2985109R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-9538 (Electronic) Linking ISSN: 00221007 NLM ISO Abbreviation: J Exp Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1540-9538
DOI:10.1084/jem.20220650